Validation of the Edinburgh postnatal depression scale (EPDS) for screening of major depressive episode among adults from the general population

Carregando...
Imagem de Miniatura
Citações na Scopus
82
Tipo de produção
article
Data de publicação
2014
Editora
BIOMED CENTRAL LTD
Indexadores
Título da Revista
ISSN da Revista
Título do Volume
Autores
MUNHOZ, Tiago N.
TAVARES, Beatriz Franck
BARBOSA, Ana Paula Pereira Neto
SILVA, Diego Mello da
ABITANTE, Morgana Sonza
DALL'AGNOL, Tatiane Abreu
SANTOS, Ina S.
Autor de Grupo de pesquisa
Editores
Coordenadores
Organizadores
Citação
BMC PSYCHIATRY, v.14, article ID 284, 9p, 2014
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background: Standardized questionnaires designed for the identification of depression are useful for monitoring individual as well as population mental health. The Edinburgh Postnatal Depression Scale (EPDS) has originally been developed to assist primary care health professionals to detect postnatal depression, but several authors recommend its use outside of the postpartum period. In Brazil, the use of the EPDS for screening depression outside the postpartum period and among non-selected populations has not been validated. The present study aimed to assess the validity of the EPDS as a screening instrument for major depressive episode (MDE) among adults from the general population. Methods: This is a validation study that used a population-based sampling technique to select the participants. The study was conducted in the city of Pelotas, Brazil. Households were randomly selected by two stage conglomerates with probability proportional to size. EPDS was administered to 447 adults (>= 20 years). Approximately 17 days later, participants were reinterviewed by psychiatrics and psychologists using a structured diagnostic interview (Mini International Neuropsychiatric Interview, MINI). We calculated the sensitivity and specificity of each cutoff point of EPDS, and values were plotted as a receiver operator characteristic curve. Results: The best cutoff point for screening depression was >= 8, with 80.0% (64.4 - 90.9%) sensitivity and 87.0% (83.3 - 90.1%) specificity. Among women the best cutoff point was >= 8 too with values of sensitivity and specificity of 84.4% (67.2 - 94.7%) and 81.3% (75.5 - 86.1%), respectively. Among men, the best cutoff point was >= 7 (75% sensitivity and 89% specificity). Conclusions: The EPDS was shown to be suitable for screening MDE among adults in the community.
Palavras-chave
Major depressive episode, Validity of tests, Sensitivity and specificity, Adult, EPDS test, Depression
Referências
  1. Alonso J, 2008, ACTA PSYCHIAT SCAND, V118, P305, DOI 10.1111/j.1600-0447.2008.01241.x
  2. Areias MEG, 1996, BRIT J PSYCHIAT, V169, P30, DOI 10.1192/bjp.169.1.30
  3. Aydin N, 2004, SOC PSYCH PSYCH EPID, V39, P483, DOI 10.1007/s00127-004-0770-4
  4. Becht MC, 2001, J AFFECT DISORDERS, V63, P209, DOI 10.1016/S0165-0327(99)00189-5
  5. Benvenuti P, 1999, J AFFECT DISORDERS, V53, P137, DOI 10.1016/S0165-0327(98)00102-5
  6. Berle JO, 2003, J AFFECT DISORDERS, V76, P151, DOI 10.1016/S0165-0327(02)00082-4
  7. Boing AF, 2012, REV SAUDE PUBL, V46, P617, DOI http://dx.doi.org/10.1590/s0034-89102012000400005
  8. Castelo MS, 2010, INT PSYCHOGERIATR, V22, P109, DOI 10.1017/S1041610209991219
  9. Cox JL, 1996, J AFFECT DISORDERS, V39, P185, DOI 10.1016/0165-0327(96)00008-0
  10. COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782
  11. Da-Silva VA, 1998, BRAZ J MED BIOL RES, V31, P799, DOI 10.1590/S0100-879X1998000600012
  12. Eberhard-Gran M, 2001, ACTA PSYCHIAT SCAND, V104, P243, DOI 10.1034/j.1600-0447.2001.00187.x
  13. Edmondson OJH, 2010, J AFFECT DISORDERS, V125, P365, DOI 10.1016/j.jad.2010.01.069
  14. Ferrari AJ, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001547
  15. Figueira Patrícia, 2009, Rev Saude Publica, V43 Suppl 1, P79
  16. Gabilondo A, 2012, GEN HOSP PSYCHIAT, V34, P510, DOI 10.1016/j.genhosppsych.2012.05.005
  17. Garcia-Esteve L, 2003, J AFFECT DISORDERS, V75, P71, DOI 10.1016/S0165-0327(02)00020-4
  18. Gibson J, 2009, ACTA PSYCHIAT SCAND, V119, P350, DOI 10.1111/j.1600-0447.2009.01363.x
  19. Goetzel RZ, 2012, HEALTH AFFAIR, V31, P2474, DOI 10.1377/hlthaff.2011.0819
  20. Halbreich U, 2006, J AFFECT DISORDERS, V91, P97, DOI 10.1016/j.jad.2005.12.051
  21. Kessler RC, 2010, DEPRESS ANXIETY, V27, P351, DOI 10.1002/da.20634
  22. Kessler RC, 2009, EPIDEMIOL PSICHIAT S, V18, P23
  23. Lai BPY, 2010, PSYCHIAT RES, V180, P80, DOI 10.1016/j.psychres.2009.07.015
  24. Lloyd-Williams M, 2000, J PAIN SYMPTOM MANAG, V20, P259, DOI 10.1016/S0885-3924(00)00182-2
  25. Marques JMD, 2008, GEN HOSP PSYCHIAT, V30, P303, DOI 10.1016/j.genhosppsych.2008.02.001
  26. Matthey S, 2001, J AFFECT DISORDERS, V64, P175, DOI 10.1016/S0165-0327(00)00236-6
  27. Meyer Christian, 2004, Evid Based Ment Health, V7, P123
  28. Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9
  29. MURRAY L, 1990, BRIT J PSYCHIAT, V157, P288, DOI 10.1192/bjp.157.2.288
  30. Pitanupong J, 2007, PSYCHIAT RES, V149, P253, DOI 10.1016/j.psychres.2005.12.011
  31. Santos IS, 2007, CAD SAUDE PUBLICA, V23, P2577, DOI 10.1590/S0102-311X2007001100005
  32. Santos IS, 2013, CAD SAUDE PUBLICA, V29, P1533, DOI 10.1590/0102-311X00144612
  33. Santos MFS, 1999, REV PSIQUIATR CLIN, V26, P90
  34. Sartorius N, 2007, LANCET, V370, P810, DOI 10.1016/S0140-6736(07)61245-8
  35. Schulze B, 2009, LANCET, V373, P362, DOI 10.1016/S0140-6736(08)61818-8
  36. Silva MT, 2014, REV BRAS PSIQUIATR, V36, P262, DOI 10.1590/1516-4446-2013-1294
  37. Spijker J, 2002, BRIT J PSYCHIAT, V181, P208, DOI 10.1192/bjp.181.3.208
  38. Thorpe K., 1993, J REPROD INFANT PSYC, V11, P119, DOI 10.1080/02646839308403204
  39. Vivilaki VG, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-329
  40. Wang YP, 2013, REV BRAS PSIQUIATR, V35, P416, DOI 10.1590/1516-4446-2012-1048